High throughput quantification of prohibited substances in plasma using thin film solid phase microextraction

Journal of Chromatography A

Volumn 1374, Issue , 2014, Pages 40-49

  Reyes Garcés, Nathaly ^a   Bojko, Barbara ^a   Pawliszyn, Janusz ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

High throughput; Plasma; Prohibited substances; Sample preparation; Solid phase microextraction; Thin film

Indexed keywords

AUTOMATION; BIOCOMPATIBILITY; FILM PREPARATION; PLASMAS; SAMPLING; THIN FILMS;

EXPERIMENTAL CONDITIONS; HIGH THROUGHPUT; HYDROPHILIC LIPOPHILIC BALANCE; POLYACRYLONITRILE (PAN); PROHIBITED SUBSTANCES; SAMPLE PREPARATION; SAMPLE PREPARATION METHODS; SOLID-PHASE MICROEXTRACTION;

EXTRACTION;

AMPHETAMINE; BENZOYLECGONINE; BISOPROLOL; BUDESONIDE; CLENBUTEROL; CODEINE; DEXAMETHASONE; EXEMESTANE; FUROSEMIDE; METHAMPHETAMINE; METOPROLOL; MORPHINE; NIKETHAMIDE; POLYACRYLONITRILE; PREDNISOLONE; PROPRANOLOL; SALBUTAMOL; STANOZOLOL; STRYCHNINE; TOREMIFENE; TRENBOLONE; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DESORPTION; HUMAN; HYDROPHILICITY; LIMIT OF QUANTITATION; LIPOPHILICITY; MEASUREMENT ACCURACY; SOLID PHASE MICROEXTRACTION; CALIBRATION; CHEMICAL PHENOMENA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; PROCEDURES; TANDEM MASS SPECTROMETRY;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; SOLID PHASE MICROEXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84916242646     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.11.047     Document Type: Article

References (41)

1. World Antidoping Agency (WADA) Prohibited List 2014, Retrieved from: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2014/WADA-prohibited-list-2014-EN.pdf (19.07.14).
2. World Antidoping Agency (WADA) Minimum Required Performance Levels 2014, Retrieved from: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/Technical_Documents/WADA-TD2014MRPL-v1-Minimum-Required-Performance-Levels-EN.pdf (19.07.14).
3. Thevis M., Thomas A., Schänzer W. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods. Anal. Bioanal. Chem. 2013, 405:9655-9667.
4. Thomas A., Geyer H., Schänzer W., Crone C., Kellmann M., Moehring T., Thevis M. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer. Anal. Bioanal. Chem. 2012, 403:1279-1289.
5. Thomas A., Guddat S., Kohler M., Krug O., Scha W., Petrou M., Thevis M. Comprehensive plasma-screening for known and unknown substances in doping controls. Rapid Commun. Mass Spectrom. 2010, 24:1124-1132.
6. Schamasch P., Rabin O. Challenges and perspectives in anti-doping testing. Bioanalysis 2012, 4:1691-1701.
7. Thevis M., Thomas A., Pop V., Schänzer W. Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: possibilities and limitations. J. Chromatogr. A 2013, 1292:38-50.
8. Schwope D.M., Scheidweiler K.B., Huestis M.A. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2011, 401:1273-1283.
9. Pedersen A.J., Dalsgaard P.W., Rode A.J., Rasmussen B.S., Müller I.B., Johansen S.S., Linnet K. Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition. J. Sep. Sci. 2013, 36:2081-2089.
10. Jones A.W., Holmgren A., Kugelberg F.C. Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden. Forensic Sci. Int. 2008, 177:133-139.
11. Rook E.J., Hillebrand M.J.X., Rosing H., van Ree J.M., Beijnen J.H. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 824:213-221.
12. Forsdahl G., Vatne H.K., Geisendorfer T., Gmeiner G. Screening of testosterone esters in human plasma. Drug Test. Anal. 2013, 5:826-833.
13. Ho E.N.M., Kwok W.H., Wong A.S.Y., Wan T.S.M. High resolution accurate mass screening of prohibited substances in equine plasma using liquid chromatography - Orbitrap mass spectrometry. Drug Test. Anal. 2013, 5:509-528.
14. Kaabia Z., Dervilly-Pinel G., Hanganu F., Cesbron N., Bichon E., Popot M.A., Bonnaire Y., Le Bizec B. Ultra high performance liquid chromatography/tandem mass spectrometry based identification of steroid esters in serum and plasma: an efficient strategy to detect natural steroids abuse in breeding and racing animals. J. Chromatogr. A 2013, 1284:126-140.
15. Thomas A., Geyer H., Guddat S., Schänzer W., Thevis M. Dried blood spots (DBS) for doping control analysis. Drug Test. Anal. 2011, 3:806-813.
16. Liu Y., Uboh C.E., Soma L.R., Li X., Guan F., You Y., Rudy J.A., Chen J.-W. Detection and confirmation of 60 anabolic and androgenic steroids in equine plasma by liquid chromatography-tandem mass spectrometry with instant library searching. Drug Test. Anal. 2011, 3:54-67.
17. Liu Y., Uboh C.E., Soma L.R., Li X., Guan F., You Y., Chen J.-W. Efficient use of retention time for the analysis of 302 drugs in equine plasma by liquid chromatography-MS/MS with scheduled multiple reaction monitoring and instant library searching for doping control. Anal. Chem. 2011, 83:6834-6841.
18. Kwok W.H., Leung D.K.K., Leung G.N.W., Wan T.S.M., Wong C.H.F., Wong J.K.Y. Screening of drugs in equine plasma using automated on-line solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2010, 1217:3289-3296.
19. Gosetti F., Mazzucco E., Gennaro M.C., Marengo E. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. J. Chromatogr. A 2013, 927:22-36.
20. French D. The challenges of LC-MS/MS ana lysis of opiates and opioids in urine. Bioanalysis 2013, 5:2803-2820.
21. Mass Spectrometry in Sports Drug Testing. Characterization of Prohibited Substances and Doping Control Analytical Assays 2010, 1-139. Wiley & Sons, Inc., Hoboken, NJ. M. Thevis (Ed.).
22. Boyaci E., Gorynski K., Rodriguez-Lafuente A., Bojko B., Pawliszyn J. Introduction of solid-phase microextraction as a high-throughput sample preparation tool in laboratory analysis of prohibited substances. Anal. Chim. Acta 2014, 809:69-81.
23. Mirnaghi F.S., Chen Y., Sidisky L.M., Pawliszyn J. Optimization of the coating procedure for a high-throughput 96-blade solid phase microextraction system coupled with LC-MS/MS for analysis of complex samples. Anal. Chem. 2011, 83:6018-6025.
24. Vuckovic D., Cudjoe E., Musteata F.M., Pawliszyn J. Automated solid-phase microextraction and thin-film microextraction for high-throughput analysis of biological fluids and ligand-receptor binding studies. Nat. Protoc. 2010, 5:140-161.
25. Vuckovic D., Cudjoe E., Hein D., Pawliszyn J. Automation of solid-phase microextraction in high-throughput format and applications to drug analysis. Anal. Chem. 2010, 80:6870-6880.
26. Risticevic S., Lord H., Górecki T., Arthur C.L., Pawliszyn J. Protocol for solid-phase microextraction method development. Nat. Protoc. 2010, 5:122-139.
27. Nilsson L.B. The bioanalytical challenge of determining unbound concentration and protein binding for drugs. Bioanalysis 2013, 5:3033-3050.
28. Abdel-Rehim M., Carlsson G., Bielenstein M., Arvidsson T., Blomberg L.G. Evaluation of solid-phase microextraction for the study of protein binding in human plasma samples. J. Chromatogr. Sci. 2000, 38:458-464.
29. Fura A., Harper T.W., Zhang H., Fung L., Shyu W.C. Shift in pH of biological fluids during storage and processing: effect on bioanalysis. J. Pharm. Biomed. Anal. 2003, 32:513-522.
30. Kodama H., Kodama Y., Itokazu N., Shinozawa S., Kanemaru R., Sugimoto T. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy. J. Clin. Pharm. Ther. 2001, 26:175-179.
31. Vogeser M., Briegel J. Effect of temperature on protein binding of cortisol. Clin. Biochem. 2007, 40:724-727.
32. Xu J., Winkler J., Derendorf H. A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma. J. Pharmacokinet. Pharmacodyn. 2007, 34:355-372.
33. Rocci M.L., D'Ambrosio R., Johnson N.F., Jusko W.J. Prednisolone binding to albumin and transcortin in the presence of cortisol. Biochem. Pharmacol. 1982, 31:289-292.
34. ChemSpider Search and Share Chemistry 2014, Retrieved from: http://www.chemspider.com/?gclid=CLWVmdX0sL8CFa4WMgod3AcAlA (06.07.14).
35. DrugBank (n.d.), Retrieved from: (06.07.14). http://www.drugbank.ca/.
36. Sköpp G., Pötsch L., Ganssmann B., Aderjan R., Mattern R. A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood. J. Anal. Toxicol. 1998, 22:261-264.
37. Sköpp G., Pötsch L., Mauden M., Richter B. Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-D9-carboxy tetrahydrocannabinol glucuronide. Forensic Sci. Int. 2002, 126:17-23.
38. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
39. Musteata M.L., Musteata F.M., Pawliszyn J. Biocompatible solid-phase microextraction coatings based on polyacrylonitrile and solid-phase extraction phases. Anal. Chem. 2007, 79:6903-6911.
40. Food and Drug Administration Guidance for Industry: Bioanalytical Method Validation 2001, Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD.
41. Mirnaghi F.S., Goryński K., Rodriguez-Lafuente A., Boyaci E., Bojko B., Pawliszyn J. Microextraction versus exhaustive extraction approaches for simultaneous analysis of compounds in wide range of polarity. J. Chromatogr. A 2013, 1316:37-43.